美股A股
StockGist
Back
6-K2026-03-10· grok-4-1-fast-non-reasoning

CANF · Can-Fite BioPharma Ltd.

0001213900-26-025718

SEC filing

Summary

Can-Fite BioPharma Ltd. filed a Form 6-K current report on March 10, 2026, with report type 6-K and no specific Items disclosed.

Key takeaways